Reaction

Iritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,000 reports · 57 co-occurring drugs

As of the last recalculation, Iritis appears in 3,000 FAERS reports alongside 57 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 82.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Faricimab	93	82.1	83.1
Prednisolone Acetate	50	34.1	34.2
Aflibercept	141	32.9	33.0
Bimatoprost	68	16.7	16.8
Dorzolamide Hydrochloride And Timolol Maleate	18	15.9	15.9
Zoledronic Acid	80	14.2	14.2
Ranibizumab	48	12.7	12.8
Travoprost	14	11.3	11.3
Naproxen	113	10.3	10.3
Standardized Senna Concentrate	18	10.0	10.0
Brimonidine Tartrate	24	9.4	9.4
Doxepin	13	8.9	8.9
Timolol	15	8.7	8.7
Infliximab-Dyyb	34	8.2	8.2
Brinzolamide	10	8.0	8.0
Etanercept	564	7.8	7.8
Doxepin Hydrochloride	14	7.7	7.7
Cefazolin	10	7.6	7.6
Timolol Maleate	10	7.0	7.0
Adalimumab-Fkjp	46	7.0	7.0
Celecoxib	123	6.7	6.7
Naproxen Sodium	130	6.6	6.6
Infliximab	194	6.5	6.5
Methadone Hydrochloride	10	6.4	6.4
Indomethacin	12	6.3	6.3
Sulfasalazine	69	6.2	6.2
Secukinumab	139	6.2	6.2
Adalimumab-Aaty	40	5.9	5.9
Moxifloxacin Hydrochloride	17	5.8	5.8
Cefazolin Sodium	10	5.8	5.8
Sirolimus	11	5.7	5.7
Adalimumab-Adaz	41	5.5	5.5
Basiliximab	9	5.3	5.3
Latanoprost	37	5.2	5.2
Methotrexate	288	5.1	5.1
Methotrexate Sodium	327	5.1	5.1
Adalimumab	420	4.6	4.6
Ezetimibe And Simvastatin	10	4.6	4.6
Bevacizumab	78	4.5	4.5
Golimumab	54	4.4	4.4
Vemurafenib	7	4.0	4.0
Acetaminophen And Codeine	7	4.0	4.0
Certolizumab Pegol	64	3.8	3.9
Naproxen Sodium Tablet, Coated	7	3.6	3.6
Naproxen Sodium, Coated Tablets	7	3.6	3.6
Naproxen Sodium 220Mg	7	3.6	3.6
Diclofenac Potassium, Film Coated	4	3.3	3.3
Diclofenac Potassium Tablets	4	3.3	3.3
Icosapent Ethyl	4	3.3	3.3
Dabrafenib	9	3.0	3.0
Encorafenib	4	2.8	2.8
Ipilimumab	16	2.6	2.6
Diclofenac Potassium	4	2.6	2.6
Trametinib	8	2.3	2.3
Cenegermin-Bkbj	4	2.3	2.3
Lifitegrast	4	1.7	1.7
Isotretinoin	12	1.7	1.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.